Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

GENB

Generate Biomedicines Inc

Mar 02 • 04:00PM ET

12.17

-0.48 -3.79 %

Healthcare • Biotechnology • USA • NASD

Feb 27, 3:01 PMWeak Nasdaq debut below IPO price sparked 25% intraday plunge.

Held by: ARKG ONEQ

Index	-	P/E	-	EPS (ttm)	-	Insider Own	-	Shs Outstand	50.30M	Perf Week	-
Market Cap	612.15M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	-	Perf Month	-
Enterprise Value	-	PEG	-	EPS next Q	-	Inst Own	-	Short Float	-	Perf Quarter	-
Income	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-
Sales	-	P/B	-	EPS next Y	-	ROA	-	Short Interest	-	Perf YTD	-3.79%
Book/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W High	15.32 -20.56%	Perf Year	-
Cash/sh	-	P/FCF	-	EPS past 3/5Y	- -	ROIC	-	52W Low	11.44 6.38%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	- -	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	2.91	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	-	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	-	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	-	EPS Q/Q	-	SMA20	-1.93%	Beta	-	Target Price	-
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-1.93%	Rel Volume	0.23	Prev Close	12.65
Employees	312	LT Debt/Eq	-	Earnings	-	SMA200	-1.93%	Avg Volume	6.22M	Price	12.17
IPO	Feb 27, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	1,457,743	Change	-3.79%

Generate Biomedicines, Inc. is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company was founded in 2018, and is headquartered in Somerville, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Grous Beth	Chief People Officer	Mar 02 '26	Buy	16.00	300	4,800	300	Mar 02 06:05 PM
Silvers Jason	President & CFO	Mar 02 '26	Buy	16.00	2,000	32,000	1,000	Mar 02 05:54 PM
AFEYAN NOUBAR	Director	Mar 02 '26	Buy	16.00	4,687,500	75,000,000	15,264,724	Mar 02 05:52 PM
Mendillo Jane L	Director	Mar 02 '26	Buy	16.00	1,500	24,000	1,500	Mar 02 05:47 PM
AFEYAN NOUBAR	Director	Mar 02 '26	Buy	16.00	4,687,500	75,000,000	15,264,724	Mar 02 05:42 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GENB

Generate Biomedicines Inc

Upgrade your FINVIZ experience